High Dose Vitamin C and Low Dose Chemo Treatment

Research has shown that intravenous high dose vitamin C in cancer therapy cannot be dismissed but that it warrants further investigation. Recent studies have made more inroads into the understanding of the role of vitamin C, bolstering more the use of the therapy by practitioners in complementary and alternative medicine. The efficaciousness of a new high dose vitamin C and low-dose chemo therapy (HiCLoChemo) reported here indicates a quantum leap in cancer treatment, which borders on the miraculous. The results of the preliminary trial on 20 patients suffering from end stage metastatic cancers, including those of the liver, lung, breast, pancreas, uterus, brain glioma, and prostate, show a remission of cancer, some complete, as confirmed by the PET/CT images before and after the treatment protocol. The components of the treatment are not new and their variational combinations have also been used before. The key difference lies in the application of the HiCLoChemo protocol, where the vitamin C infused first, facilitates the delivery of the chemo drugs at the microenvironment of the tumor. The paper discusses the vital role of vitamin C and factors that lead to the inducement of the immune system being recruited to join in the cancer battle. The aim is to enlist cancer researchers, oncologists and cancer treatment centers to undertake clinical trials of the HiCLoChemo protocol. With confirmation of the findings, the treatment will represent a game-changer as it offers a treatment for terminal cancers that promises cancer remission at affordable cost, which is sorely needed.